What is the share price of GPT Healthcare Ltd (GPTHEALTH) today?
The share price of GPTHEALTH as on 10th July 2026 is ₹158.11. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on GPT Healthcare Ltd (GPTHEALTH) share?
The past returns of GPT Healthcare Ltd (GPTHEALTH) share are- Past 1 week: -0.96%
- Past 1 month: 4.50%
- Past 3 months: 12.95%
- Past 6 months: 16.47%
- Past 1 year: -2.98%
- Past 3 years: N/A%
- Past 5 years: -21.22%
What are the peers or stocks similar to GPT Healthcare Ltd (GPTHEALTH)?
The peers or stocks similar to GPT Healthcare Ltd (GPTHEALTH) include:What is the dividend yield % of GPT Healthcare Ltd (GPTHEALTH) share?
The current dividend yield of GPT Healthcare Ltd (GPTHEALTH) is 1.58.What is the market cap of GPT Healthcare Ltd (GPTHEALTH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of GPT Healthcare Ltd (GPTHEALTH) is ₹1297.37 Cr as of 10th July 2026.What is the 52 week high and low of GPT Healthcare Ltd (GPTHEALTH) share?
The 52-week high of GPT Healthcare Ltd (GPTHEALTH) is ₹185 and the 52-week low is ₹115.What is the PE and PB ratio of GPT Healthcare Ltd (GPTHEALTH) stock?
The P/E (price-to-earnings) ratio of GPT Healthcare Ltd (GPTHEALTH) is 30.73. The P/B (price-to-book) ratio is 5.23.Which sector does GPT Healthcare Ltd (GPTHEALTH) belong to?
GPT Healthcare Ltd (GPTHEALTH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy GPT Healthcare Ltd (GPTHEALTH) shares?
You can directly buy GPT Healthcare Ltd (GPTHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
GPT Healthcare Ltd
GPTHEALTH Share Price
NSE₹158.110.13% (-0.21)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
GPTHEALTH Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
GPTHEALTH Performance & Key Metrics
GPTHEALTH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 30.72 | 5.23 | 1.58% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 43.49 | 6.23 | 0.53% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
GPTHEALTH Company Profile
GPT Healthcare is engaged in the operation of multidisciplinary private hospitals and pharmacies.
APOLLOHOSP
PE Ratio
65.47
65.47
1Y Return
20.14%
20.14%
Buy Reco %
86.67
86.67
MAXHEALTH
PE Ratio
74.77
74.77
1Y Return
11.47%
11.47%
Buy Reco %
83.33
83.33
FORTIS
PE Ratio
70.15
70.15
1Y Return
25.15%
25.15%
Buy Reco %
85.00
85.00
ASTERDM
PE Ratio
107.73
107.73
1Y Return
34.84%
34.84%
Buy Reco %
100.00
100.00
PE Ratio
51.11
51.11
1Y Return
2.90%
2.90%
Buy Reco %
85.71
85.71
GPTHEALTH Sentiment Analysis
GPTHEALTH Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
GPTHEALTH Stock Summary · May 2026
Strong underlying operational momentum was tempered by new‑hospital ramp costs, with Q4 revenue of INR 128 crore (up 24% year‑on‑year) and FY26 EBITDA of INR 90.1 crore (18.8% margin) reflecting both growth and dilution from Raipur’s start‑up losses. Management emphasized improving occupancies, higher patient throughput and specialty mix—particularly Salt Lake’s robotic program and advanced GI surgery, which supported ARPOB gains to INR 39,200 and improved bed productivity—while noting that Raipur’s commissioning generated a negative EBITDA of INR 13.8 crore and increased depreciation and finance costs, pulling down consolidated margins versus mature hospitals’ adjusted EBITDA of INR 103.9 crore and a 23.06% margin. They stressed disciplined capital allocation, developer funding that has de‑risked most Jamshedpur capex, selective M&A for 150–200 bed targets and continued clinical expansion across the network. For FY27 management reiterated roughly 15% revenue growth including Raipur, ARPOB growth of about 7–8% and an expected EBITDA margin expansion of roughly 100 basis points to about 20.2%, with Raipur expected to reach monthly operational breakeven by Q3 and roughly 30% occupancy by year‑end.
GPTHEALTH Stock Growth Drivers
GPTHEALTH Stock Growth Drivers
6Favorable sector fundamentals driving long-term demand
The macro environment underpinning the company’s market is materially positive, with secular trends such as
Differentiated, technology‑led tertiary clinical capabilities
The network has invested in advanced tertiary capabilities that position it competitively for higher‑acuity care,
GPTHEALTH Stock Challenges
GPTHEALTH Stock Challenges
4New-hospital ramp-up underperformance and consolidated profitability drag
New greenfield hospitals have materially underperformed versus expectations and are diluting consolidated profitability. The newly
Insurance empanelment delays and payer-mix/revenue-quality risk
Delays in obtaining insurance and corporate empanelments for new hospitals are constraining patient volumes, skewing
GPTHEALTH Forecast
GPTHEALTH Forecasts
Price
Revenue
Earnings
GPTHEALTH Share Price Forecast
GPTHEALTH Share Price Forecast
2026
Current
₹158.11
Baseline
Forecast for Jul 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹158.11
Baseline
Forecast for Jul 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
GPTHEALTH Company Revenue Forecast
GPTHEALTH Company Revenue Forecast
2026
Current
₹478.50
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2026
Current
₹478.50
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
GPTHEALTH Stock EPS (Earnings Per Share) Forecast
GPTHEALTH Stock EPS (Earnings Per Share) Forecast
2026
Current
₹5.15
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹5.15
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
GPTHEALTH
GPTHEALTH
Income
Balance Sheet
Cash Flow
Quarterly Normal View
GPTHEALTH Income Statement
GPTHEALTH Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 97.77 | 101.02 | 100.06 | 108.47 | 104.09 | 102.98 | 108.67 | 120.25 | 121.58 | 128.00 | ||||||||||
Operating & Other expenses | 75.59 | 76.25 | 79.84 | 82.24 | 80.94 | 80.71 | 89.74 | 96.17 | 99.45 | 103.00 | ||||||||||
EBITDA | 22.18 | 24.77 | 20.22 | 26.23 | 23.15 | 22.27 | 18.93 | 24.08 | 22.13 | 25.00 | ||||||||||
| Depreciation/Amortization | 4.50 | 4.76 | 4.68 | 4.80 | 4.67 | 4.88 | 6.18 | 6.85 | 7.11 | 6.95 | ||||||||||
| PBIT | 17.68 | 20.01 | 15.54 | 21.43 | 18.48 | 17.39 | 12.75 | 17.23 | 15.02 | 18.05 | ||||||||||
| Interest & Other Items | 1.69 | 1.59 | 0.86 | 0.74 | 0.85 | 1.02 | 1.63 | 2.16 | 2.26 | 2.18 | ||||||||||
| PBT | 15.99 | 18.42 | 14.68 | 20.69 | 17.63 | 16.37 | 11.12 | 15.07 | 12.76 | 15.87 | ||||||||||
| Taxes & Other Items | 4.52 | 5.60 | 4.70 | 5.87 | 5.37 | 3.48 | 3.43 | 4.47 | 3.39 | 1.30 | ||||||||||
| Net Income | 11.47 | 12.82 | 9.98 | 14.82 | 12.26 | 12.89 | 7.69 | 10.60 | 9.37 | 14.57 | ||||||||||
| EPS | 1.44 | 1.59 | 1.21 | 1.81 | 1.49 | 1.57 | 0.94 | 1.29 | 1.14 | 1.78 |
GPTHEALTH Company Updates
GPTHEALTH Stock Peers
GPTHEALTH Past Performance & Peer Comparison
GPTHEALTH Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| GPT Healthcare Ltd | 30.73 | 5.23 | 1.58% |
| Apollo Hospitals Enterprise Ltd | 65.47 | 11.45 | 0.23% |
| Max Healthcare Institute Ltd | 74.77 | 10.04 | 0.18% |
| Fortis Healthcare Ltd | 70.15 | 7.97 | 0.10% |
GPTHEALTH Stock Price Comparison
Compare GPTHEALTH with any stock or ETFCompare GPTHEALTH with any stock or ETF
GPTHEALTH
GPTHEALTH Holdings
GPTHEALTH Shareholdings
GPTHEALTH Promoter Holdings Trend
GPTHEALTH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
GPTHEALTH Institutional Holdings Trend
GPTHEALTH Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
GPTHEALTH Shareholding Pattern
GPTHEALTH Shareholding Pattern
GPTHEALTH Shareholding History
GPTHEALTH Shareholding History
Foreign Institutions
Mutual Funds Invested in GPTHEALTH
Mutual Funds Invested in GPTHEALTH
No mutual funds holding trends are available
Top 3 Mutual Funds holding GPT Healthcare Ltd
| Funds (Top 3) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.5931% | Percentage of the fund’s portfolio invested in the stock 0.17% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 118/273 (-53) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.5920% | Percentage of the fund’s portfolio invested in the stock 0.51% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 58/79 (-23) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0004% | Percentage of the fund’s portfolio invested in the stock 0.03% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 115/130 (-5) |
Compare 3-month MF holding change on Screener
smallcases containing GPTHEALTH stock
smallcases containing GPTHEALTH stock
Looks like this stock is not in any smallcase yet.
GPTHEALTH Events
GPTHEALTH Events
GPTHEALTH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
GPTHEALTH Dividend Trend
No dividend trend available
GPTHEALTH Upcoming Dividends
GPTHEALTH Upcoming Dividends
Cash Dividend
Ex DateEx DateJul 30, 2026
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 30, 2026
GPTHEALTH Past Dividends
GPTHEALTH Past Dividends
Cash Dividend
Ex DateEx DateNov 14, 2025
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 14, 2025
Cash Dividend
Ex DateEx DateJul 29, 2025
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 29, 2025
Cash Dividend
Ex DateEx DateNov 28, 2024
Interim 1
Interim 1 | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 28, 2024
Cash Dividend
Ex DateEx DateJul 18, 2024
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 18, 2024
Cash Dividend
Ex DateEx DateApr 2, 2024
Interim 2
Interim 2 | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Apr 2, 2024
GPTHEALTH Stock News & Opinions
GPTHEALTH Stock News & Opinions
Articles & Videos
Corporate
Corporate
GPT Healthcare to convene AGMGPT Healthcare announced that the 37th Annual General Meeting(AGM) of the company will be held on 6 August 2026.
1 month agoCapital Market - Live
Spotlight
Spotlight
GPT Healthcare rallies after Q4 PAT rises 13% YoY to Rs 15 croreRevenue from operations jumped 24.62% YoY to Rs 126.37 crore in the quarter ended 31 March 2026. However, profit before tax declined 3.11% to Rs 15.86 crore, compared with Rs 16.37 crore in the year-ago period. For the full financial year FY26, the company reported a 15.42% decline in net profit to Rs 42.22 crore, even as revenue from operations increased 16.07% to Rs 472.55 crore. Meanwhile, the company's board has recommended a final dividend of Rs 1.50 per equity share of face value Rs 10 each (15%) for FY26, subject to shareholder approval at the ensuing 37th Annual General Meeting. The dividend, if approved, will be paid within 30 days of declaration, and the record date has been fixed as 30 July 2026. GPT Healthcare, the healthcare arm of the GPT Group, currently owns and operates over 561 beds spread across four state-of-the-art multi-specialty hospitals in the eastern part of the country under the brand name ILS Hospitals. Founded in 2000 in Salt Lake, Kolkata, ILS Hospitals has since expanded its footprint and capabilities. Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Earnings
GPT Healthcare standalone net profit rises 13.03% in the March 2026 quarterNet profit of GPT Healthcare rose 13.03% to Rs 14.57 crore in the quarter ended March 2026 as against Rs 12.89 crore during the previous quarter ended March 2025. Sales rose 24.63% to Rs 126.37 crore in the quarter ended March 2026 as against Rs 101.40 crore during the previous quarter ended March 2025. For the full year,net profit declined 15.42% to Rs 42.22 crore in the year ended March 2026 as against Rs 49.92 crore during the previous year ended March 2025. Sales rose 16.08% to Rs 472.55 crore in the year ended March 2026 as against Rs 407.09 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales126.37101.40 25 472.55407.09 16 OPM %18.4920.41 -17.8220.48 - PBDT22.8221.25 7 81.9088.38 -7 PBT15.8716.37 -3 54.8169.35 -21 NP14.5712.89 13 42.2249.92 -15 Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Spotlight
GPT Healthcare Q4 PAT rises 13% YoY to Rs 15 croreRevenue from operations jumped 24.62% YoY to Rs 126.37 crore in the quarter ended 31 March 2026. However, profit before tax declined 3.11% to Rs 15.86 crore, compared with Rs 16.37 crore in the year-ago period. For the full financial year FY26, the company reported a 15.42% decline in net profit to Rs 42.22 crore, even as revenue from operations increased 16.07% to Rs 472.55 crore. Meanwhile, the company's board has recommended a final dividend of Rs 1.50 per equity share of face value Rs 10 each (15%) for FY26, subject to shareholder approval at the ensuing 37th annual general meeting. The dividend, if approved, will be paid within 30 days of declaration, and the record date has been fixed as 30 July 2026. GPT Healthcare, the healthcare arm of the GPT Group, currently owns and operates over 561 beds spread across four state-of-the-art multi-specialty hospitals in the eastern part of the country under the brand name ILS Hospitals. Founded in 2000 in Salt Lake, Kolkata, ILS Hospitals has since expanded its footprint and capabilities. The counter slipped 2.51% to Rs 138.10 on the BSE. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Board of GPT Healthcare recommends final dividendGPT Healthcare announced that the Board of Directors of the Company at its meeting held on 18 May 2026, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.
1 month agoCapital Market - Live
Corporate
Corporate
GPT Healthcare to convene board meetingGPT Healthcare will hold a meeting of the Board of Directors of the Company on 18 May 2026.
1 month agoCapital Market - Live
Earnings
Earnings
GPT Healthcare standalone net profit declines 23.51% in the December 2025 quarterNet profit of GPT Healthcare declined 23.51% to Rs 9.37 crore in the quarter ended December 2025 as against Rs 12.25 crore during the previous quarter ended December 2024. Sales rose 17.56% to Rs 120.16 crore in the quarter ended December 2025 as against Rs 102.21 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales120.16102.21 18 OPM %17.2420.80 - PBDT19.8722.29 -11 PBT12.7617.62 -28 NP9.3712.25 -24 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
GPT Healthcare to discuss resultsGPT Healthcare will hold a meeting of the Board of Directors of the Company on 2 February 2026.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
Board of GPT Healthcare recommends interim dividendGPT Healthcare announced that the Board of Directors of the Company at its meeting held on 8 November 2025, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Earnings
GPT Healthcare standalone net profit declines 28.48% in the September 2025 quarterNet profit of GPT Healthcare declined 28.48% to Rs 10.60 crore in the quarter ended September 2025 as against Rs 14.82 crore during the previous quarter ended September 2024. Sales rose 12.54% to Rs 118.91 crore in the quarter ended September 2025 as against Rs 105.66 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales118.91105.66 13 OPM %19.1222.17 - PBDT21.9225.49 -14 PBT15.0720.69 -27 NP10.6014.82 -28 Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 13.97%, vs industry avg of 16.23%
Over the last 5 years, market share decreased from 0.59% to 0.52%
Over the last 5 years, net income has grown at a yearly rate of 14.89%, vs industry avg of 54.92%